The primary aim was to assess the impact of this combination therapy on serum hormone levels, especially IGF-1, as well as to explore whether these agents could augment the anabolic environment provided by testosterone [2]
When it comes to weight management, this personalized care helps providers and patients partner on the right medication, which may or may not include a GLP-1
Suchankova P, Yan J, Schwandt M et al (2015) The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: evidence from human genetic association studies and a mouse model of alcohol dependence
The estimated effects on blood glucose and body weight were largest in 2021, immediately after GLP-1s were included in the VHA formulary
While not specifically approved for weight loss, many patients with type 2 diabetes experience notable weight reduction, sometimes exceeding 1012% of body weight, particularly at higher doses
This triple-agonist profile is what makes Retatrutide UK the subject of intense research interest in 2026